Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02050048 · ClinicalTrials.gov registry record · Phase 2
High Volume Lactated Ringer's Solution and Pancreatitis
A Phase 2 study, sponsored by Endeavor Health.
- Terminated
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT02050048 is a Phase 2 study that was terminated before completion, run by Endeavor Health. The registered enrollment target is 26 participants.
The verdict
NCT02050048, a Phase 2 study, was terminated before completion, sponsored by Endeavor Health.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether giving large amounts of intravenous (IV) fluids will reduce the risk of developing a complication known as post-ERCP pancreatitis (PEP). Pancreatitis is inflammation of the pancreas, and it is the most frequent serious complication of ERCP. Typically, a small amount of IV fluids are given during this procedure (\~ 1 liter). We are testing whether using a larger amount of fluids (2 - 3 liters) will reduce the risk of PEP.
Interventions
- OTHER Administration of Lactated Ringer's (LR) Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02050048
The ClinicalTrials.gov registry entry for NCT02050048 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Administration of Lactated Ringer's (LR) Solution is the first listed.
NCT02050048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02050048 about?
NCT02050048 is a clinical study titled "High Volume Lactated Ringer's Solution and Pancreatitis". The purpose of this study is to examine whether giving large amounts of intravenous (IV) fluids will reduce the risk of developing a complication known as post-ERCP pancreatitis (PEP). Pancreatitis is inflammation of the pancreas, and it is the most frequent serious complication of ERCP. Typically, ...
What is the current status of trial NCT02050048?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2014-01. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02050048?
The interventions under investigation include: Administration of Lactated Ringer's (LR) Solution (OTHER).
Who is sponsoring clinical trial NCT02050048?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.